Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy

Journal of Infectious Diseases

Volumn 202, Issue 3, 2010, Pages 416-426

  Soares, Milena Botelho Pereira ^a,b   De Lima, Ricardo Santana ^a   Rocha, Leonardo Lima ^a   Vasconcelos, Juliana Fraga ^a   Rogatto, Silvia Regina ^c,d   Dos Santos, Ricardo Ribeiro ^a,b   Iacobas, Sanda ^g   Goldenberg, Regina Coeli ^e   Iacobas, Dumitru Andrei ^g   Tanowitz, Herbert Bernard ^g   De Carvalho, Antonio Carlos Campos ^e,f   Spray, David Conover ^g  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; BETA3 INTEGRIN; CATHEPSIN; CATHEPSIN H; CATHEPSIN S; CD11B ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD52 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CHLORDANE; CYTOKINE RECEPTOR; GALECTIN 3; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10 RECEPTOR ALPHA; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE INHIBITOR; PADGEM PROTEIN; PROTEIN LYSINE 6 OXIDASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HISTOCOMPATIBILITY COMPLEX; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MOUSE; MYOCARDITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DNA MICROARRAY; FIBROSIS; GENE EXPRESSION PROFILING; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY;

ANIMALS; CHAGAS CARDIOMYOPATHY; CYTOKINES; FEMALE; FIBROSIS; GENE EXPRESSION PROFILING; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MYOCARDITIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRYPANOSOMA CRUZI;

EID: 77954738641     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653481     Document Type: Article

References (50)

1. World Health Organization. Chagas' disease: important advances in elimination of transmission in four countries in Latin America. Geneva, Switzerland: WHO Feature 1995; 183:1-3.
2. Dias JCP, Coura JR. Epidemiologia. In: Dias JCP, Coura JR, eds. Clínica e terapĉutica da doença de Chagas: uma abordagem prática para o clínico geral. 2nd ed. Brazil: Fundaçã o Oswaldo Cruz, 1997:36-66.
3. Rosenbaum MB. Chagasic myocardiopathy. Prog Cardiovasc Dis 1964; 7:199-225.
4. Chiale PA, Rosenbaum MB. Clinical and pharmacological characterization and treatment of potentially malignant arrythmias of chronic chagasic cardiomiopathy. In: Williams EMV, Campbell TJ, eds. Handbook of experimental pharmacology. Ed 5. Springer-Verlag, 1989: 601-620.
5. Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M. Chagas' disease. Clin Microbiol Rev 1992; 5:400-419.
6. Petkova SB, Huang H, Factor SM, et al. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2001; 31:499-511.
7. Soares MB, Pontes-De-Carvalho L, Ribeiro-dos-Santos R. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 2001; 73:547-559.
8. Garcia S, Ramos CO, Senra JF, et al. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrob Agents Chemother 2005; 49:1521-1528.
9. Federici EE, Abelmann WN, Neva FA. Chronic and progressive myocarditis in C3H mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1964; 13:272-280.
10. Iacobas DA, Fan C, Iacobas S, Spray DC, Haddad GG. Transcriptomic changes in developing kidney exposed to chronic hypoxia. Biochem Biophys Res Comm 2006; 349(1):329-338.
11. Iacobas DA, Iacobas S, Li WE, Zoidl G, Dermietzel R, Spray DC. Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. Physiol Genomics 2005; 20:211-223.
12. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002; 31:19-20.
13. Cunha-Neto E, Rizzo LV, Albuquerque F, et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1998; 31:133-137.
14. Gomes JA, Bahia-Oliveira LM, Rocha MO, et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 2005; 73:7960-7966.
15. Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167:416-423.
16. Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002; 86:123-130.
17. Kurrelmeyer KM, Michael LH, Baumgarten G, et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemicinduced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 2000; 97:5456-5461.
18. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann, DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92:1487-1493.
19. Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006; 20:1589-1598.
20. Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation 2004; 109:1892-1897.
21. Ramani R, Mathier M, Wang P, et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. Am J Physiol Heart Circ Physiol 2004; 287:H1369-377.
22. Defer N, Azroyan A, Pecker F, Pavoine C. TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J Biol Chem 2007; 282:35564-35573.
23. Rossi MA, Souza AC. Is apoptosis a mechanism of cell death of cardiomyocytes in chronic chagasic myocarditis? Int J Cardiol 1999; 68: 325-331.
24. da Silva RP, Gordon S. Phagocytosis stimulates alternative glycolysation of macrosialin (mouse CD68), a macrophage-specific endosomal protein. Biochem J 1999; 338:687-694.
25. Aliberti JC, Machado FS, Gazzinelli RT, Teixeira MM, Silva JS. Plateletactivating factor induces nitric oxide synthesis in Trypanosoma cruziinfected macrophages and mediates resistance to parasite infection in mice. Infect Immun 1999; 67:2810-2814.
26. Penna C, Alloatti G, Cappello S, et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 2005; 288:H2512-H2520.
27. Laucella S, Salcedo R, Castan-os-Velez E, et al. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunol 1996; 18:227-239.
28. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, Wittner M, Tanowitz HB. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun 1999; 67:5434-5440.
29. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular 426 - JID 2010:202 (1 August) - Soares et al adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem 1995; 270:933-943.
30. Vray B, Camby I, Vercruysse V, et al. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 2004; 14:647-657.
31. Kleshchenko YY, Moody TN, Furtak VA, Ochieng J, Lima MF, Villalta F. Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infect Immun 2004; 72:6717-6721.
32. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 1998; 66:4690-4695.
33. Aliberti JC, Machado FS, Souto JT, et al. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 1999; 67:4819-4826.
34. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000; 102:3003-3008.
35. Kolattukudy PE, Quach T, Bergese S, et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 1998; 152:101-111.
36. Shen Y, Xu W, Chu YW, Wang Y, Liu QS, Xiong SD. Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 2004; 78: 12548-12556.
37. Talvani A, Ribeiro CS, Aliberti JC, et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000; 2:851-866.
38. Turner JE, Steinmetz OM, Stahl RA, Panzer U. Targeting of Th1- associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases. Mini Rev Med Chem 2007; 7:1089-1096.
39. Gong X, Feng H, Zhang S, Yu Y, Li J,Wang J, Guo B. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody. J Mol Cell Cardiol 2007; 42:781-791.
40. Marino AP, da Silva A, dos Santos P, et al. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 2004; 110:1443-1449.
41. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996; 184:1101-1109.
42. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362:697-703.
43. Schenk S, Mal N, Finan A, et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007;25: 245-251.
44. Soares MB, Lima RS, Rocha LL, et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 2004; 164:441-447.
45. Souza RR. Aging of myocardial collagen. Biogerontology 2002; 3:325-335.
46. Milting H, Ellinghaus P, Seewald M et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 2008; 27:589-596.
47. Garg N, Popov VL, Papaconstantinou J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta 2003; 1638:106-120.
48. Mukherjee S, Belbin TJ, Spray DC, et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res 2003; 91:187-196.
49. Mukherjee S, Nagajyothi F, Mukhopadhyay A, et al. Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics 2008; 91:423-432.
50. Cunha-Neto E, Dzau VJ, Allen PD, et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 2005; 167:305-313.